Cayston and Staphylococcal sepsis - a phase IV clinical study of FDA data

Summary:

Staphylococcal sepsis is reported as a side effect among people who take Cayston (aztreonam), especially for people who are male, 40-49 old, also take Tamiflu, and have Infective pulmonary exacerbation of cystic fibrosis.

The phase IV clinical study analyzes which people have Staphylococcal sepsis when taking Cayston. It is created by eHealthMe based on reports of 5,305 people who have side effects when taking Cayston from the FDA, and is updated regularly.

What is Cayston?

Cayston has active ingredients of aztreonam. It is often used in cystic fibrosis. eHealthMe is studying from 5,310 Cayston users. Check the latest studies of Cayston.

What is Staphylococcal sepsis?

Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria) is found to be associated with 686 drugs and 935 conditions by eHealthMe. Check the latest studies of Staphylococcal sepsis.

On Jul, 27, 2026

5,305 people reported to have side effects when taking Cayston.
Among them, 18 people (0.34%) have Staphylococcal sepsis.

Could Cayston cause Staphylococcal sepsis?

Among these 18 people:

What is the gender of people who have Staphylococcal sepsis when taking Cayston? *

female: 0.0 %
male: 100 %

What is the age of people who have Staphylococcal sepsis when taking Cayston? *

What are other drugs people take besides Cayston? *

Tamiflu: 18 people, 100.00%
Pulmozyme: 16 people, 88.89%
Tobramycin: 8 people, 44.44%
Meropenem: 8 people, 44.44%
Hydrocortisone: 8 people, 44.44%
Ciprofloxacin: 8 people, 44.44%
Budesonide: 8 people, 44.44%
Vancomycin Hydrochloride: 7 people, 38.89%
Azithromycin: 7 people, 38.89%
Xolair: 6 people, 33.33%

What are other side effects people have besides Staphylococcal sepsis? *

Sepsis (a severe blood infection that can lead to organ failure and death): 18 people, 100.00%
Erythema Multiforme (a type of hypersensitivity reaction): 18 people, 100.00%
Rash Morbilliform (a rash that looks like measles): 17 people, 94.44%
Staphylococcal Infection (an infection with staphylococcus bacteria): 2 people, 11.11%
Rash Pruritic (redness with itching): 2 people, 11.11%
Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 2 people, 11.11%
Infective Pulmonary Exacerbation Of Cystic Fibrosis (severe infective lung disease with production of abnormally thick mucus): 2 people, 11.11%
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 2 people, 11.11%
Rash Erythematous (redness of the skin): 1 person, 5.56%

What are the existing conditions these people have? *

Influenza Like Illness: 18 people, 100.00%
Infective Pulmonary Exacerbation Of Cystic Fibrosis (severe infective lung disease with production of abnormally thick mucus): 18 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cayston and have Staphylococcal sepsis?

- Check whether Staphylococcal sepsis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cayston:

Cayston (5,310 reports)

Browse all side effects of Cayston:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Staphylococcal sepsis:

Staphylococcal sepsis (687 drugs)

Browse all the conditions that are associated with Staphylococcal sepsis:

Staphylococcal sepsis (935 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aztreonam (the active ingredients of Cayston) and Cayston (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.